Clinical trials
Pathologic Complete Response trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Netherlands Cancer Institute | 2 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
| J. W. A. Burger | 1 |
| Maastricht Radiation Oncology | 1 |
| Maastricht University | 1 |
| UMC Utrecht | 1 |
| University Medical Center Groningen | 1 |
| Xenikos | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 10 |
| Breast Neoplasms | 2 |
| Rectal Neoplasms | 2 |
| Esophageal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Hypersensitivity | 1 |
| Lung Neoplasms | 1 |
| Lymphoma, Follicular | 1 |
| Neoplasm, Residual | 1 |
| Nutrition Disorders | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.